Orchid Pharma Stock Surges on U.S. FDA Inspection Report for TN Unit
Shares of Orchid Pharma surged 14.3 percent intraday Thursday on getting successful inspection closure report from the US health regulator for Tamil Nadu unit.
"Orchid received establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) based on the successful inspection closure for formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India," says the Chennai-based healthcare firm in its filing.
"Orchid received establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) based on the successful inspection closure for formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India," says the Chennai-based healthcare firm in its filing.